Skip to main content

Ally Bridge Group (NY) LLC

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1822947 NEW YORK, NY

Position in IKT

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$2,226,000
New position
Shares Held
1,325,000
first reported quarter
Ownership
0.950%
of shares outstanding
% of Portfolio
2.37%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ally Bridge Group (NY) LLC holds $75,058,438 across 22 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in IKT

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $2,226,000 1,325,000